The inhibition of γ-secretase as a therapeutic approach to Alzheimer's disease

被引:26
|
作者
Tomita, T [1 ]
Iwatsubo, T [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan
关键词
D O I
10.1358/dnp.2004.17.5.829036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's disease is a dementing neurodegenerative disorder for which there is no effective treatment at present. Genetic and biological studies provide evidence that the production and deposition of amyloid-beta peptides (Abeta) contribute to the etiology of Alzheimer's disease. gamma-Secretase is the pivotal enzyme in generating the C terminus of Abeta, which determines its aggregability and speed of deposition. Drugs that regulate the production of Abeta by inhibiting gamma-secretase activity could provide an effective therapy for Alzheimer's disease, although recent studies suggest that gamma-secretase plays important roles in cellular signaling. This review focuses on studies of the gamma-secretase biology and provides the direction for developing effective and selective gamma-secretase inhibitors as drugs for the treatment of Alzheimer's disease. (C) 2004 Prous Science. All rights reserved.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 50 条
  • [1] Beta-secretase inhibition as a therapeutic target for Alzheimer's disease
    Tang, J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S3 - S3
  • [2] Activation of the α-Secretase Processing of AβPP as a Therapeutic Approach in Alzheimer's Disease
    Vincent, Bruno
    Govitrapong, Piyarat
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 : 75 - 94
  • [3] The search for α-secretase and its potential as a therapeutic approach to Alzheimer's disease
    Hooper, NM
    Turner, AJ
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (11) : 1107 - 1119
  • [4] γ-Secretase as a Therapeutic Target in Alzheimer's Disease
    Guardia-Laguarta, C.
    Pera, M.
    Lleo, A.
    [J]. CURRENT DRUG TARGETS, 2010, 11 (04) : 506 - 517
  • [5] Inhibition of γ-secretase as a therapeutic intervention for Alzheimer's disease -: Prospects, limitations and strategies
    Evin, Genevieve
    Sernee, Marijke Fleur
    Masters, Colin L.
    [J]. CNS DRUGS, 2006, 20 (05) : 351 - 372
  • [6] β-Secretase as a therapeutic target for Alzheimer’s disease
    Arun K. Ghosh
    Sandra Gemma
    Jordan Tang
    [J]. Neurotherapeutics, 2008, 5 : 399 - 408
  • [7] Therapeutic potential of α-secretase in Alzheimer's disease
    Yang, HQ
    Chen, SD
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2006, 33 (02) : 109 - 115
  • [8] β-secretase as a therapeutic target for Alzheimer's disease
    Ghosh, Arun K.
    Gemma, Sandra
    Tang, Jordan
    [J]. NEUROTHERAPEUTICS, 2008, 5 (03) : 399 - 408
  • [9] Inhibition and modulation of γ-secretase for Alzheimer’s disease
    Michael S. Wolfe
    [J]. Neurotherapeutics, 2008, 5 : 391 - 398
  • [10] γ-secretase inhibition and modulation for Alzheimer's disease
    Wolfe, Michael S.
    [J]. CURRENT ALZHEIMER RESEARCH, 2008, 5 (02) : 158 - 164